Skip to main content

Contact Perrigo

  

Contact Us

Questions Regarding our Products or to Report an Adverse Event

Over the Counter Products
+1 800 719 9260
Contact Us

Infant Formula, Nutritional 
+1 800 272 5095
Contact Us

Ranir - a Perrigo Oral Care Company
+1 866 532 6041 
Contact Us


On July 6, 2021, Perrigo sold its former Rx Pharmaceuticals Business, which now operates independent of Perrigo under the name of Padagis, LLC.

Contact Padagis
+1 800-775-2054

Find Padagis online:
United States

Health care professionals and consumers with medical information inquiries, product complaints, or adverse event reports regarding PRIALT® (ziconitide intrathecal infusion), please contact Jazz Pharmaceuticals at +1 888 774 2581.

Health care professionals and consumers with medical information inquiries, product complaints, or adverse event reports regarding MAXIPIME® (cefepime hydrochloride, USP) for Injection or AZACTAM® (aztreonam for injection, USP), please contact Bristol Myers Squibb Medical Information (BMS) at +1 800 321 1335 or by email at Drug.Information@bms.com.

Corporate Headquarters

The Sharp Building
Hogan Place
Dublin 2, Ireland
+353 1 709 4000

Registered in Ireland
Registration Number 529592

North American Base of Operations
430 Monroe Avenue NW
Grand Rapids, MI 49503
+1 269 673 8451

New Business Questions Inquiry Form



Investor and Media Relations

Brad Joseph
Vice President Global Investor Relations
Global Investor Relations and Corporate Communications
Bradley.Joseph@perrigo.com
+1 269 686 3373

Nick Gallagher
Senior Manager Global Investor Relations
Global Investor Relations & Corporate Communications
Nicholas.Gallagher@perrigo.com
269-686-3238

Investor.Request@perrigo.com